Rock Soffer
CIK: 0001845308
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Longeveron Inc.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Aug 19, 2026LGVN
Longeveron Inc.
Award(A)Direct36K shares- - Jul 15, 2025LGVN
Longeveron Inc.
Award(A)Direct17K shares- - May 30, 2025LGVN
Longeveron Inc.
Sale(S)Direct11K shares at avg. $1.25$14K - May 29, 2025LGVN
Longeveron Inc.
Sale(S)Direct10K shares at avg. $1.30$13K - May 22, 2025LGVN
Longeveron Inc.
Sale(S)Direct2K shares at avg. $1.32$3K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 19, 2026 | LGVN Longeveron Inc. | Award(A) | 36,000 | - | $0 | Direct |
| Jul 15, 2025 | LGVN Longeveron Inc. | Award(A) | 17,000 | - | - | Direct |
| May 30, 2025 | LGVN Longeveron Inc. | Sale(S) | 11,000 | $1.25 | $13,750 | Direct |
| May 29, 2025 | LGVN Longeveron Inc. | Sale(S) | 10,000 | $1.30 | $13,000 | Direct |
| May 22, 2025 | LGVN Longeveron Inc. | Sale(S) | 2,000 | $1.32 | $2,640 | Direct |
1-5 of 5 transactions
About Soffer Rock
Soffer Rock (SEC CIK 0001845308) files insider reports with the SEC as Director of Longeveron Inc. (LGVN).
Signal8 holds 4 ownership filings by Soffer Rock, all Form 4s, filed between May 27, 2025 and Aug 21, 2026. Those filings report 5 transactions, from May 22, 2025 to Aug 19, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Soffer Rock's filings is in MIAMI, FL.
Recent filings by Soffer Rock
- Aug 19, 2026: Grant or award of LGVN shares (Form 4, code A).
- Jul 15, 2025: Grant or award of LGVN shares (Form 4, code A).
- May 30, 2025: Open-market sale of LGVN shares (Form 4, code S).
- May 29, 2025: Open-market sale of LGVN shares (Form 4, code S).
- May 22, 2025: Open-market sale of LGVN shares (Form 4, code S).
Other insiders filing for Longeveron Inc. (LGVN)
- Jhaveri Nirav S., Chief Financial Officer
- Willard Stephen H, Chief Executive Officer
- Agafonova Nataliya, Chief Medical Officer
- Lehr Paul T, General Counsel, Secretary
- Blass Devin, CTO & SVP of CMC
- Hajjar Roger Joseph, Director